Inventor · disambiguated record
Wataru Akahata
Also filed as: AKAHATA WATARU
22 granted patents·14 pending applications·125 citations·filing 2006–2025
94Inventor score
Files withVLP THERAPEUTICS LLC12VLP THERAPEUTICS INC8US HEALTH5NABEL GARY J2THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
36 records- 0195US11718647B2Virus-like particles and methods of useUS HEALTH·Filed 2021·Granted Aug 8, 2023·2 cites·14 claims
- 0295US9487563B2Virus-like particles and methods of useNABEL GARY J·Filed 2012·Granted Nov 8, 2016·18 cites·19 claims
- 0395US9353353B2Virus-like particles (VLPs) prepared from chikungunya virus structural proteinsNABEL GARY J·Filed 2009·Granted May 31, 2016·29 cites·9 claims
- 0494US9249191B2Virus like particle compositionVLP THERAPEUTICS LLC·Filed 2013·Granted Feb 2, 2016·23 cites·14 claims
- 0592US11098084B2Virus-like particles and methods of useTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Aug 24, 2021·3 cites·10 claims
- 0691US10138277B2Virus-like particles and methods of useUS HEALTH·Filed 2016·Granted Nov 27, 2018·3 cites·9 claims
- 0791US9969986B2Virus like particle comprising modified envelope protein E3VLP THERAPEUTICS LLC·Filed 2015·Granted May 15, 2018·11 cites·16 claims
- 0891US9512190B2Malaria vaccineVLP THERAPEUTICS LLC·Filed 2014·Granted Dec 6, 2016·14 cites·18 claims
- 0991US2025326801A1Virus-like particles and methods of useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 1090US10098943B2Flavivirus virus like particleVLP THERAPEUTICS LLC·Filed 2015·Granted Oct 16, 2018·5 cites·16 claims
- 1189US12281336B2Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteinsUS HEALTH·Filed 2024·Granted Apr 22, 2025·0 cites·5 claims
- 1288US10369208B2Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteinsUS HEALTH·Filed 2016·Granted Aug 6, 2019·5 cites·6 claims
- 1388US10166281B2Method and composition for modulating immune responseVLP THERAPEUTICS LLC·Filed 2016·Granted Jan 1, 2019·3 cites·7 claims
- 1488US9637532B2Virus like particle comprising PD-1 antigen or PD-1 ligand antigenVLP THERAPEUTICS LLC·Filed 2014·Granted May 2, 2017·9 cites·22 claims
- 1587US12168675B2Virus-like particles and methods of useUS HEALTH·Filed 2023·Granted Dec 17, 2024·0 cites·12 claims
- 1680US11992523B2Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteinsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT·Filed 2022·Granted May 28, 2024·0 cites·4 claims
- 1777US11369674B2Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteinsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Jun 28, 2022·0 cites·7 claims
- 1876US2025129342A1Alphavirus replicon particleVLP THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1975US2024401081A1Cytokine immunotherapyVLP THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2071US12227770B2Alphavirus replicon particleVLP THERAPEUTICS INC·Filed 2021·Granted Feb 18, 2025·0 cites·14 claims
- 2168US12134777B2Alphavirus replicon vector and immunotherapy by administering sameVLP THERAPEUTICS INC·Filed 2021·Granted Nov 5, 2024·0 cites·17 claims
- 2267US2025228931A1Alphavirus replicon encoding chimeric sars-cov-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2366US12280102B2Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2021·Granted Apr 22, 2025·0 cites·16 claims
- 2466US2024335528A1Efficient vaccineVLP THERAPEUTICS JAPAN INC·Filed 2024·Application pending·0 cites
- 2565US2023330209A1Treatment of inflammatory conditionsCYN K LLC·Filed 2023·Application pending·0 cites
- 2665US2023391833A1Modified vaccine design developmentsVLP THERAPEUTICS JAPAN INC·Filed 2023·Application pending·0 cites
- 2758US11345726B2Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope proteinVLP THERAPEUTICS INC·Filed 2015·Granted May 31, 2022·0 cites·13 claims
- 2858US2019185822A1Alphavirus replicon particleVLP THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 2958US2023201333A1Efficient vaccineVLP THERAPEUTICS JAPAN LLC·Filed 2022·Application pending·0 cites
- 3058US2019351041A1Malaria vaccineVLP THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 3158US2022347261A1Galectin-targeting immunotherapyVLP THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3253US10464986B2Virus like particle comprising PD-1 antigen or PD-1 ligand antigenVLP THERAPEUTICS LLC·Filed 2017·Granted Nov 5, 2019·0 cites·17 claims
- 3352US2017035871A1Malaria vaccineVLP THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 3451US10385101B2Virus like particle comprising modified envelope protein E3VLP THERAPEUTICS LLC·Filed 2016·Granted Aug 20, 2019·0 cites·20 claims
- 3548US2009155853A1Non-viral gene delivery complexNABEL GARY·Filed 2006·Application pending·0 cites
- 3640US2017252425A1Zika virus virus like particleVLP THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wataru Akahata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →